Discover investment opportunities in Top 100 Stocks Under $12 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 100 Stocks Under $12 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 100 Stocks Under $12 using our Smart AI Filter.
9 stocks found for "Top 100 Stocks Under $12"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.20 Risk measure | ±100.0% Price volatility | -1.6 Valuation | 0.00% Annual yield | |||
1.54 Risk measure | ±48.3% Price volatility | 17.8 Valuation | 0.00% Annual yield | |||
1.05 Risk measure | ±36.3% Price volatility | 8.2 Valuation | 9.82% Annual yield | |||
0.80 Risk measure | ±36.6% Price volatility | 21.0 Valuation | 3.68% Annual yield | |||
1.00 Risk measure | ±36.4% Price volatility | 10.6 Valuation | 2.60% Annual yield | |||
1.00 Risk measure | ±57.1% Price volatility | 11.5 Valuation | 0.00% Annual yield | |||
1.59 Risk measure | ±66.3% Price volatility | -117.2 Valuation | 0.36% Annual yield | |||
0.66 Risk measure | ±31.9% Price volatility | 12.2 Valuation | 24.56% Annual yield | |||
1.07 Risk measure | ±57.3% Price volatility | 64.0 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: Why do some investors focus on stocks like GDRX priced under $12?
A: Investors looking at GDRX and similarly priced stocks often seek high growth potential, as these stocks might be undervalued opportunities. Low price points can allow investors to acquire larger positions, but these stocks may come with higher volatility and risk.
Q: How does UA's (Under Armour) performance affect its investment appeal?
A: Under Armour has faced competitive pressure in the athletic wear market, impacting growth. Its ability to innovate and expand globally affects investor interest, especially for those focused on consumer discretionary sectors.
Q: What are the dividend prospects for stocks like NYCB?
A: NYCB is known for offering attractive dividends among the displayed stocks. However, investors should evaluate its financial health and payout sustainability, considering broader interest rate changes impacting financial institutions.
Q: How might geopolitical factors affect a company like UMC in the semiconductor industry?
A: UMC, operating in semiconductors, may be sensitive to geopolitical issues like trade tensions which could disrupt supply chains or impact cost structures, affecting its market performance.
Q: Are stocks like COTY in the consumer goods sector known for stability?
A: COTY, in the consumer goods sector, may provide stability due to consistent demand for its products. However, the discretionary nature of beauty products can lead to fluctuations tied to economic conditions.
Q: What risks should be considered when investing in technology-related stocks like DNA?
A: DNA, involved in technology, may be subject to risks such as rapid technological change, competitive pressure, and regulatory challenges, often leading to higher volatility compared to more established sectors.
Blue Owl is backing about 100 athletes competing in professional tennis tournaments around the world this year. It's part of the firm's strategy to raise brand awareness primarily among high-net-worth individuals, and part of a broader effort to bring alternative asset managers out of obscurity.
Read moreHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read moreMerely a year ago, Coty Inc. stock (NYSE: COTY) was priced around $10, but it now hovers close to $4, having declined more than 50% from its peak. This significant drop is indicative of more than just market fluctuations—it highlights the pressures that are heavily impacting one of the largest beauty firms globally.
Read moreNovo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx Holdings Inc. to offer it at the same price at US pharmacies. Bloomberg's Madison Muller reports.
Read moreAfter reaching an important support level, Ginkgo Bioworks Holdings, Inc. (DNA) could be a good stock pick from a technical perspective. DNA surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.
Read more